Christophe Schilling

Christophe Schilling is an accomplished professional in the biotechnology sector, currently serving as Chief Executive Officer at Geno since January 2000. In addition to this role, Christophe Schilling has held a position on the Board of Directors for BIOCOM since February 2010 and previously served on the Board of Directors for GT Life Sciences from July 2007 to April 2011. Educational qualifications include a PhD in Bioengineering from UC San Diego and a B.S.E. in Biomedical Engineering from Duke University.